HF
TEVA icon

HRT Financial’s Teva Pharmaceuticals TEVA Stock Holding History

HRT Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.85M Buy
+227,500
New +$7.32M 0.02% 812
2020
Q2 		– Sell
-23,900
Closed -$214K – 1753
2020
Q1 		$214K Buy
+23,900
New +$245K 0.01% 562
2019
Q2 		– Sell
-14,800
Closed -$232K – 911
2019
Q1 		$232K Buy
+14,800
New +$261K 0.04% 354

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's TEVA Position: Q1 2026 in Review

HRT Financial increased its Teva Pharmaceuticals (TEVA) stake by 998% in Q1 2026, buying an estimated $4.1M and bringing the position to 140,222 shares worth $4.22M. The position accounts for 0.01% of the portfolio, ranked #1110.

HRT Financial first reported a position in TEVA in Q4 2018 and has held it in 13 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • HRT Financial held 140,222 shares of Teva Pharmaceuticals worth $4.22M as of Q1 2026.
  • HRT Financial bought 127,457 Teva Pharmaceuticals shares in Q1 2026, an estimated $4.1M.
  • Teva Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1110 holding.
  • HRT Financial first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 13 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.